secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0000950170-24-074032
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus board member Dr. Yong Ben adopts 10b5-1 plan for up to 10,607 shares
---------------------------------------------------------------------------

- Dr. Yong Ben, a board member, adopted a Rule 10b5-1 trading plan on June 14, 2024.
- Plan authorizes sale of up to 10,607 shares of CRBP common stock.
- Sales may begin September 12, 2024; plan terminates September 11, 2025.
- Plan is intended to satisfy affirmative defense under Rule 10b5-1(c).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024074032/0000950170-24-074032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024074032/crbp-20240614.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-074032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer